2023 Conference Program Day 1

Dr. Tammy S. Cohen,

BS, PharmD, MS, FASHP, FTSHP, FACHEVice President of Pharmacy, Baylor, Scott & White Health, Texas, | USA

Tammy S. Cohen, BS, PharmD, MS, FASHP, FTSHP, FACHE is the Vice- President of Pharmacy Services at Baylor Scott and White Health in Dallas, Texas. Her responsibilities span pharmacy practice across many settings to include ambulatory care, inpatient and retail practice sites. She oversees the pharmacy services of the 27 hospitals and 31 retail pharmacy locations within BSWH. Tammy leads and serves on many multi-disciplinary committees and has been instrumental in leading financial and operational efficiencies that cross the organization and implementing clinical services. Tammy has been active in several pharmacy organizations. She has been a member of the Texas Society of Health System Pharmacists (TSHP) Board of Directors in various capacities since 2006; most recently she served as the Immediate-Past President. She is also currently a member of the American Society of Health System Pharmacists (ASHP) Pharmacy Executive Leadership Academy. Additional previous TSHP roles include: serving as chair of the Council of Organizational Affairs, Chair of the Section of Pharmacy Management, member of the TSHP Education Council and as the TSHP representative to the Texas State Board Pharmacy (TSBP) Task Force on Internships. Additional organization activities include formal roles with ASHP and the local societies of health system pharmacy along with numerous regulatory related task forces. ASHP experiences include serving on the Council on Legal and Public Affairs, a member of the steering committee for the ASHP Leadership Meeting, the Chair of the Advisory Group on Publications for the Section for Inpatient Practitioners and a member of the Section of Financial Management for the Section of Pharmacy Practice Management. "

Dr. Trisha A. Jordan

PharmD, MS, Chief Pharmacy Officer, Ohio State University Wexner Medical Cente, | USA

"Trisha A. Jordan, PharmD, MS is currently the Chief Pharmacy Officer and Director for the Health-System Pharmacy Administration Residency Program at The Ohio State University Wexner Medical Center and Assistant Dean for Medical Center Affairs at the OSU College of Pharmacy. In her role, Trisha leads pharmacy services across the enterprise, with a focus on providing patient centered pharmacy care through innovation, education and research. After completing undergraduate studies, Trisha received her doctor of pharmacy degree from the University of Michigan and a Master’s degree in health-system pharmacy administration from The Ohio State University. She also completed a pharmacy administration residency at Ohio State and earned a Lean Six Sigma Green Belt certification through the Fisher College of Business at The Ohio State University. Trisha’s professional goals have centered on improving patient care outcomes by creating advanced pharmacy practice models to improve the safety and efficacy in medication use. Her research focuses on pharmacy services and their effect on quality, safety, and cost in addition to the impact of the changing role of the pharmacist in health-systems. She is involved in professional pharmacy organizations and dedicates time to advocacy efforts at the state and national level.

Dr. Majid R. Tanas

PharmD, MHA, MS, FASHP, Vice President of Pharmacy & Chief Pharmacy Officer for Legacy Health. | USA

Dr. Tanas has sought to help others in the profession by mentoring, speaking at conferences, and elevating pharmacy practice at the state and national level. In 2009, Dr. Tanas helped lead the remediation of Oregon Board of Pharmacy findings of non-compliance for Remote IV Dispensing. Through this effort, statutes for Oregon were developed to support Remote IV Dispensing - many of which became a model for others to reference. By this endeavor, oncology-trained Health-System Pharmacists remotely managed Pharmacy Technicians in cleanrooms across 100 miles of freeway. This model allowed Pharmacy Technicians to practice at a higher level as they were able to function independently. As a part of Specialty Pharmacy expansion within Oregon, Dr. Tanas spearheaded the Specialty Pharmacy team to expand critical specialty medications to Oregonians by achieving URAC accreditation, building a specialty program, and developing ambulatory practices to reach more patients. In 2015, The National Institutes of Health Clinical Center had significant FDA 483 findings in their cleanroom. This impact halted much of NIH-sponsored research. After a nationwide search, Dr. Tanas was selected to become the Chief of Pharmacy due to his cleanroom and remediation expertise. During his tenure, he established a team to address significant operational changes to modernize current regulatory practice standards, design the first Health-System cGMP compliant 503A cleanroom, increase the department FTE by nearly double, and expand resources for research. In the midst of a challenging transition, Dr. Tanas made the difficult decision to issue a nationwide recall for medications due to quality concerns. His leadership ultimately led the NIH Clinical Center to initiate a medication safety and quality program and instituted daily organization-wide safety huddles. Currently, Dr. Tanas leads a multi-hospital health system at Legacy Health Pharmacy Services to elevate their cleanroom and regulatory practices. He has directed remodels at five hospitals across the region, upgraded to automated dispensing cabinets for safer medication delivery systems, established a technician-led compliance team for diversion prevention, achieved URAC/ACHC Specialty Pharmacy accreditation, and expanded 340b outpatient clinic services. During the pandemic, his leadership and collaboration with adjoining health systems across the region resulted in the nation's fifth-largest mass vaccination site. Throughout his career, Dr. Tanas has exemplified a commitment to patient safety and compliance by creating unique systems to deliver pharmaceutical care. He continues to give back to the pharmacy community by mentoring student and resident pharmacists to challenge their paradigm around patient care. In addition, he creates opportunities for both technicians and pharmacists to advance their careers in unique care models.

Mr. Jerry Yik

MPubPol, Head of Policy and Advocacy, SHPA, | Australia

Jerry leads SHPA’s diverse policy and advocacy activities, highlighting health and pharmacy policy issues to the relevant stakeholders including parliamentarians, government departments, regulatory bodies, clinical and safety agencies. Harnessing member expertise, SHPA's Policy and Advocacy team demonstrates the continuing expertise, innovation and high standard the hospital pharmacy sector sets, as well as the challenges faced by the sector to provide high quality, safe, equitable and accessible pharmacy services to Australian patients in all healthcare settings.

Prof. Albert Wertheimer

PhD, MBA,Nova Southeastern University | USA

Dr. Albert Wertheimer has been active in sociobehavioral and administrative pharmacy research and education for more than 30 years. He earned a pharmacy degree at the University of Buffalo, an M.B.A. from the State University of New York at Buffalo and his Ph.D. at Purdue University. In addition, he completed a post-doctoral research fellowship in the department of social medicine at St. Thomas” Hospital Medical School of the University of London. He has directed nearly 100 Ph.D. students and more than that number of master’s students. He is the author or editor of 40 books, numerous book chapters and about 430 journal articles. He has lectured or consulted in about 75 countries, and he holds visiting professor appointments at universities in Mexico, Taiwan, Turkey, Slovenia and China. He performed pioneering work in the area of social and behavioral sciences in pharmacy and in more recent years has conducted research in pharmaco-economics, outcomes research, and health policy analysis. Prior to his appointment at NSU, he has been a professor at Temple University, dean of the Philadelphia College of Pharmacy, a researcher at Merck and Company, a vice president of First Health, Inc., a Pharmacy Benefit Manager and a professor and director of graduate studies at the University of Minnesota. Dr. Wertheimer has received many awards and recognitions including fellowships from the American Association of Pharmaceutical Scientists and the International Pharmacy Federation (FIP). He is Scheele Laureate and an honorary member of several professional societies. He has been a study section member/grant reviewer for the US NIH and for AHRQ. Current research interests include pharmaceutical counterfeiting, off label prescribing and cost:benefit studies.

Dr. Diane B. Ginsburg

Ph.D., M.S., R.Ph., FASHP Professor, Pharmacy Practice, Associate Dean for Healthcare Partnerships, The University of Texas at Austin, College of Pharmacy, | USA

Dr. Ginsburg completed her B.S. in Pharmacy at the University of Pittsburgh School of Pharmacy and M.S. at the University of Houston College of Pharmacy. She completed a two-year ASHP-accredited residency in hospital pharmacy administration at The Methodist Hospital in Houston, Texas. She received her Doctor of Philosophy degree in higher education administration and leadership in the College of Education at the University of Texas at Austin. She is currently Clinical Professor in the Pharmacy Practice Division, Associate Dean for Healthcare Partnerships, and G.D. Searle Endowed Fellow in Pharmacy at the University of Texas at Austin, College of Pharmacy. She is an adjunct instructor in the Drug Enforcement Administration Teaching Academy and a Gallup-Certified Strengths Coach.

Dr. Sarah S. Almuhisen,

Pharm.D., BCIDP Infectious Diseases Clinical Pharmacist King Fahad Medical City (KFMC) Riyadh, | Saudi Arabia

Sarah Almuhisen, PharmD, BCIDP is an Infectious disease clinical pharmacist at King Fahad Medical city (KFMC), Riyadh. She is American and Saudi Board Certified in Infectious Disease pharmacotherapy (BCIDP), Antimicrobial Stewardship Pharmacist from American Society of infectious disease pharmacists (SIDP). She is completed PGY1 Pharmacy Practice Residency at King Fahad medical city then completed PGY2 Infectious Disease pharmacy residency at Prince Sultan Military Medical City (PSMMC). Pharm. D graduated from Princess Nora bint Abdulrahman University College of Pharmacy with first class honors. Currently, she is an active board member in infectious disease pharmacy specialty network (ID-PSN) in Saudi Society of Clinical Pharmacy (SSCP) as well as member in antimicrobial stewardship committee at KFMC.

Dr. Thamer A. Almangour,

Pharm.D., BCPS, BCIDP Asst. Prof, Infectious Diseases Pharmacotherapy Consultant & Director, Infectious Diseases Pharmacy Residency Program, King Saud University | Saudi Arabia

Dr. Thamer Almangour graduated with bachelor’s degree of pharmaceutical science from King Saud University where he started his career as a teaching assistant. He graduated with Doctor of Pharmacy degree from Massachusetts, followed by a residency from Massachusetts General Hospital, Boston, Massachusetts. He completed a second year of specialty residency in infectious diseases from Midtown Medical Center, Columbus, Georgia. He also completed 2 years of post-doctoral fellowship in infectious diseases from University of North Carolina at Chapel Hill. He is board certified in pharmacotherapy and board certified in infectious diseases. He has around 40 publications and book chapter in the area of infectious diseases. He started his professional career as Assistant Professor in the college of pharmacy at King Saud University, Riyadh, Saudi Arabia in 2019 and consultant clinical pharmacy specialist in the area of infectious diseases in King Saud University Medical City. He became the PharmD internship program supervisor at the college of pharmacy and the infectious diseases pharmacy residency program director at the University Hospital

Dr. Saleh Saeed Alzahrani

Pharm.D., BCCCP Clinical Pharmacist Specialist-Adult Critical Care Pharmacy Services Department Security Forces Hospital Program | Saudi Arabia

Clinical Pharmacist Specialist – Adult Critical Care, Pharmacy Services, Security Forces Hospital Program – Riyadh. Saleh Alzahrani is a Critical Care Clinical Pharmacist at Security Forces Hospital Program - Riyadh, he earned his Doctor of Pharmacy (Pharm.D) degree from King Abdulaziz University in 2009. He has done his PGY-1 clinical pharmacy at Security Forces Hospital Program – Riyadh in 2013 - 2015, and his PGY-2 in Critical Care at King Saud University Medical City in 2021 - 2022. Dr. Alzahrani became an American Board-Certified Critical Care Pharmacist (BCCCP) in 2018.

Dr. Saleh Ayed Al Anazi

Manager of Quality Improvement Pharmaceutical Care Services King Abdulaziz Medical City Riyadh, | Saudi Arabia

Manager Quality pharmaceutical care services in King Abdulaziz medical city in Riyadh. Faculty member at the College of Pharmacy, King Saud bin Abdulaziz University for Health Science. Adjunct assistant professor at Almaarefa University. Adjunct assistant professor at Prince Sattam Bin Abdulaziz University. Surveyor in Saudi Central Board for Accreditation of Healthcare Institutions (CBAHI) in pharmacy. Hold Ph.D. degree in pharmaceutical science from King Saud University 2020, hold master degree in pharmaceutical science from king Saud University 2015, and master degree in total quality management from The Arab Academy for Science and Technology and Maritime Transport, Alexandria, Egypt 2006. Also Certified Patient Safety Officer (CPSO), AIHQ since April 2015, with lots of Courses inpatient and medication Safety and quality. Certified CPHQ September 2016. Lean Six Sigma Yellow Belt Certified February 18 -19th, 2015, Lean Six-Sigma Green Certified February 20 -22, 2015. Member in Medication Safety Program in National Guard.

Dr. Fakhr Z. AlAyoubi,

M.Sc., R Pharm, MBA President, of Cardio Clinical Pharmacy Group Saudi Heart Association, Clinical Pharmacist Adjunct Asst. Prof, College of Pharmacy, King Saud University | Saudi Arabia

Credentials: Master's in business administration, master's in clinical pharmacy, Board in Heart Failure, and Arab Board in Cardiology Pharmacy Specialty. Work Experience: Currently, President of the Cardiology Pharmacy Group at the Saudi Heart Association Pharmacy. the research head of metabolic syndrome, pharmacotherapy, and clinical practice, with more than 30 publications, in international and national journals, one of the most important bleeding risks score multivariable modules for Non-Valvular Atrial Fibrillation using Direct Oral Thrombin Inhibitor (DOAC) in the Arab population. Previous: Head of Ambulatory care, & Head of Clinical Pharmacy Server at King Khalid University Hospital. Conducted numerous clinical trials, established, and implemented different national guidelines and multi-disciplinary programs

Dr. Miteb Alanazi

B.Sc. (Pharm.), M.Sc. Hematology, Oncology Pediatric Clinical Pharmacist Drug& Poison Information Center Adjunct Clinical Assistant Professor King Saud University Medical City | Saudi Arabia

Miteb Alanazi is a senior pediatric oncology clinical pharmacist at King Saud University Medical City. He started his career in the pharmacy field since 2003. Dr. Miteb earned his master degree in clinical pharmacy from the pharmacy college at King Saud University. He acted as out-patient pharmacy assistant director from 2011-2015. Also, he was the director of pharmacy research center and toxicology lab from 2011-2013. Dr. Miteb is an active member of many professional societies such as “Saudi Oncology Pharmacy Assembly”, “American Association of College of Pharmacy”, and “Saudi Pharmaceutical Society”. Additionally, Dr. Miteb is the co-chair for the Vaccine Advisory Committee at King Saud University Medical City. Beside his professional duties, Dr. Miteb is participating in teaching and training numerous courses and students from different colleges of pharmacy

Prof. Osama Ibrahim

Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah | United Arab Emirates

.

Dr. Hamzah Tareq Al Zubaidi

Department of Pharmacy Practice & Pharmacotherapy, College of Pharmacy, University of Sharjah | United Arab Emirates

.

Dr. Nadia AL Mazrouei

Department of Pharmacy Practice & Pharmacotherapy, College of Pharmacy, University of Sharjah | United Arab Emirates

.

Prof. Eman Abu-Gharbieh

Sharjah Institute for Medical Research, University of Sharjah, Department of Clinical Sciences, College of Medicine, University of Sharjah | United Arab Emirates

-

Dr. Rana Ibrahim

Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, College of Pharmacy, | United Arab Emirates

.

Dr. Mohd Shara

Dept. of Pharmacy Practice & Pharmacotherapeutics, University of Sharjah, College of Pharmacy | United Arab Emirates

.

Dr. Feras Jassim Jirjees

Department of Pharmacy Practice & Pharmacotherapeutics, College of Pharmacy, University of Sharjah | United Arab Emirates

.

Dr. Khalid Al Kubaisi

Visiting Lecturer, Pharmacy Practice & Pharmacotherapeutics, College of Pharmacy, University of Sharjah | United Arab Emirates

.